Document is current
Any future updates will be listed below
-
Authors
Uwimana, Aline
Alexiou, Hélène
Mutoni, Jean d’Amour
Robert, Annie
Rujeni, Nadine
Cani, Patrice D.
Coutelier, Jean-Paul
Mutesa, Léon
Everard, Amandine
-
Funding
Funding for this research was provided by:
Académie de recherche et d'enseignement supérieur
FNRS FRFS-WELBIO (WELBIO-CR-2022A-02P, WELBIO X.1517.24)
FNRS EOS (40007505)
Fonds De La Recherche Scientifique - FNRS (T.0115.24)
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 16 September 2025
First Online: 14 October 2025
Declarations
:
: A.E. and P.D.C. are inventors on patent applications dealing with the use of Akkermansia muciniphila and its components in the treatment of metabolic disorders. A. E. and P.D.C. are inventors on patent applications dealing with gut microbes in food reward dysregulations. A.E. is inventor on patent applications dealing with the use of bacteria metabolites in the prevention or treatment of respiratory viral infections P.D.C. was cofounder of Enterosys. All other authors declare they have no competing interests.
